Global Microneedle Market 2024

Global Microneedle Market 2024

According to latest analysis, the global microneedle market was USD 1,282.6 million in 2023 and is expected to reach USD 1,733.8 million in 2030 and register a CAGR of 4.4% during the forecast period, 2024-2030. The increasing demand for dermatology procedures and minimally invasive drug delivery methods is also a major contributor. Additionally, the rising incidence of infectious diseases further propels market expansion.

Microneedles have demonstrated remarkable versatility across numerous applications. Various clinical trials and studies have highlighted their efficacy in delivering drugs and vaccines in a cost-effective manner, which is particularly crucial for developing nations. Microneedles designed for delivering biological macromolecules and immunobiological agents come in various forms, including solid, hollow, coated, dissolving, and hydrogel types. Each type is distinguished by needle length, carefully engineered to penetrate the stratum corneum without damaging nerve endings.

Moreover, microneedles are increasingly employed in drug delivery systems for treating a wide range of diseases, including the growing number of infectious diseases. This multifaceted utility and the ongoing advancements in microneedle technology underscore their pivotal role in the evolving landscape of medical treatments and drug delivery solutions.

This comprehensive industry report provides market estimates and forecasts, accompanied by a detailed examination of the product, application, and region aspects. It delivers a quantitative analysis of the market, empowering stakeholders to leverage existing market opportunities. Furthermore, the report identifies key segments for potential opportunities and strategies, drawing insights from market trends and the approaches of leading competitors.

The global microneedle market has been extensively analyzed by categorizing it according to various sub-segments in order to provide accurate forecasts of industry size and assess trends within specific areas.

The global market for microneedle can be segmented by product: coated microneedles, dissolving microneedles, hollow microneedles, hydrogel microneedles, solid microneedles. In 2023, the solid microneedles segment made up the largest share of revenue generated by the microneedle market.

Microneedle market is further segmented by application: dermatology, disease diagnosis, disease treatment, immunobiological administration. The disease treatment segment was the largest contributor to the global microneedle market in 2023.

Based on region, the microneedle market is segmented into: Asia-Pacific, Europe, North America, Rest of the World (RoW). North America is estimated to account for the largest share of the global microneedle market.

The report explores the recent developments and profiles of key vendors in the Global Microneedle Market, including Becton, Dickinson and Company (BD), Candela Laser Corporation, CosMED Pharmaceutical Co., Ltd., Cutera, Inc., Cynosure, LLC., Debiotech S.A., LTS Lohmann Therapie-Systeme AG, Mercator MedSystems, Inc., Micropoint Technologies Pte Ltd, nanoBioSciences, LLC, NanoPass Technologies Ltd., RAPHAS Co., Ltd., TheraJect, Inc., Vaxess Technologies, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Why Choose This Report

Gain a reliable outlook of the global microneedle market forecasts from 2024 to 2030 across scenarios.

Identify growth segments for investment.

Stay ahead of competitors through company profiles and market data.

The market estimate for ease of analysis across scenarios in Excel format.

Strategy consulting and research support for three months.

Print authentication provided for the single-user license.

Market Segments Covered in Global Microneedle Industry Analysis:

i.) Product

• Coated microneedles
• Dissolving microneedles
• Hollow microneedles
• Hydrogel microneedles
• Solid microneedles

ii.) Application

• Dermatology
• Disease diagnosis
• Disease treatment
• Immunobiological administration

iii.) Region

• Asia-Pacific
• Europe
• North America
• Rest of the World (RoW)